Poster discussion
Pathogenic mechanisms of lung transplant complications: a focus on CLAD
LATE-BREAKING ABSTRACT: Challenging immunosuppression treatment in lung transplant patients with kidney failure: Rescue therapy with basiliximab?
N. Kohli(London, United Kingdom)
COI
1
LATE-BREAKING ABSTRACT: Ex vivo pulmonary ultrasound: A new tool for the assessment of marginal organs?
L. Thakuria(London, United Kingdom)
COI
2
LATE-BREAKING ABSTRACT: Lung transplantation in cystic fibrosis patients in Israel: The importance of ethnicity and nutritional status
H. Levine(Even Yehuda, Israel)
COI
3
The role of secondary lymphoid tissue in airway obliteration in a heterotopic trachea transplant model
J. Somers(Leuven, Belgium)
COI
4
Serum cytokines patterns in lung transplant recipients
L. Morlacchi(Milano (MI), Italy)
COI
5
System biology (SB) allows the identification of pathogenic micro RNA (miR) in BOS
E. Rossi(Pavia (PV), Italy)
COI
6
Blood mRNA and miRNA transcriptome to predict chronic lung allograft dysfunction
P. Royer(Nantes, France)
COI
7
Engineered gold nanoparticles targeted to mesenchymal cells from BOS patients can be safely administered to normal mice by inhalation
E. Cova(Pavia (PV), Italy)
COI
8
Different expression of CD44variant6 in BAL mesenchymal cells is related to BOS severity
E. Cova(Pavia (PV), Italy)
COI
9
Torque teno virus kinetics after lung transplantation and its association to immunosuppression schemes and to clinical complications
P. Jaksch(wien, Austria)
COI
10
Neurogenic pulmonary edema and right ventricular dysfunction in an animal model of brain death
A. Belhaj(Yvoir, Belgium)
COI
11
Neurogenic pulmonary edema: Effect of corticosteroids
A. Belhaj(Yvoir, Belgium)
COI
12
Airway blood flow changes after lung transplantation
G. Horváth(Budapest, Hungary)
COI
13
The effect of immunosuppression on airway integrity
H. Bellon(Leuven, Belgium)
COI
14
Risk factors for chronic lung allograft dysfunction (CLAD) in the SysCLAD cohort
A. Koutsokera(Lausanne, Switzerland)
COI
15
Early and late viral infections after lung transplantation
F. Patrucco(Torino (TO), Italy)
COI
16
The role of cytomegalovirus in the development of bronchiolitis obliterans syndrome
I. Zinnatullin(St. Petersburg, Russian Federation)
COI
17
. . .
